[go: up one dir, main page]

GB0310979D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0310979D0
GB0310979D0 GBGB0310979.0A GB0310979A GB0310979D0 GB 0310979 D0 GB0310979 D0 GB 0310979D0 GB 0310979 A GB0310979 A GB 0310979A GB 0310979 D0 GB0310979 D0 GB 0310979D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0310979.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Pliva Farmaceutika dd
Original Assignee
Glaxo Group Ltd
Pliva Farmaceutika dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Farmaceutika dd filed Critical Glaxo Group Ltd
Priority to GBGB0310979.0A priority Critical patent/GB0310979D0/en
Publication of GB0310979D0 publication Critical patent/GB0310979D0/en
Priority to CL200401009A priority patent/CL2004001009A1/en
Priority to PCT/EP2004/005085 priority patent/WO2004101589A1/en
Priority to ARP040101610A priority patent/AR044305A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0310979.0A 2003-05-13 2003-05-13 Novel compounds Ceased GB0310979D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0310979.0A GB0310979D0 (en) 2003-05-13 2003-05-13 Novel compounds
CL200401009A CL2004001009A1 (en) 2003-05-13 2004-05-11 COMPOUNDS DERIVED FROM MACROLIDS OF 14 OR 15 MEMBERS, REPLACED IN POSITION 4 "; PROCEDURE FOR PREPARATION; PHARMACEUTICAL COMPOSITION THAT INCLUDES IT; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF SYSTEMIC MICROBIAL OR TOPICAL INFECTIONS
PCT/EP2004/005085 WO2004101589A1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 membered-ring compounds
ARP040101610A AR044305A1 (en) 2003-05-13 2004-05-11 MACROLIDO COMPOUND OF 14 AND 15 MEMBERS REPLACED IN POSITION 4 '', PROCEDURE FOR THE PREPARATION OF THE SAME, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0310979.0A GB0310979D0 (en) 2003-05-13 2003-05-13 Novel compounds

Publications (1)

Publication Number Publication Date
GB0310979D0 true GB0310979D0 (en) 2003-06-18

Family

ID=9957979

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0310979.0A Ceased GB0310979D0 (en) 2003-05-13 2003-05-13 Novel compounds

Country Status (4)

Country Link
AR (1) AR044305A1 (en)
CL (1) CL2004001009A1 (en)
GB (1) GB0310979D0 (en)
WO (1) WO2004101589A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2566085A1 (en) * 2004-05-06 2005-11-17 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O Ester linked macrolides useful for the treatment of microbial infections
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
JP2008540503A (en) 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ Ether-linked macrolides useful for the treatment of bacterial infections
CN101906125B (en) * 2010-07-13 2012-11-14 山东大学 4''-benzimidazole-5-formacyl-ester carbazate clarithomycin derivative and midbody
CN103130848B (en) * 2013-02-22 2015-07-08 中国人民解放军第二军医大学 Macrolide antibacterial compounds, and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
CL2004001009A1 (en) 2005-03-18
WO2004101589A1 (en) 2004-11-25
AR044305A1 (en) 2005-09-07

Similar Documents

Publication Publication Date Title
GB0308114D0 (en) Novel compounds
GB0305918D0 (en) Novel compounds
GB0308185D0 (en) Novel compounds
GB0308333D0 (en) Novel compounds
GB0304424D0 (en) Novel compounds
EP1596860A4 (en) Novel compounds
EP1648885A4 (en) Novel compounds
GB0310984D0 (en) Novel compounds
GB0305426D0 (en) Novel compounds
GB0304809D0 (en) Novel compounds
GB0302431D0 (en) Novel compounds
GB0302546D0 (en) Novel compounds
GB0304803D0 (en) Novel compounds
GB0305293D0 (en) Novel compounds
GB0301872D0 (en) Novel compounds
GB0301608D0 (en) Novel compounds
GB0302988D0 (en) Novel compounds
GB0303464D0 (en) Novel compounds
GB0303467D0 (en) Novel compounds
GB0304408D0 (en) Novel compounds
GB0301593D0 (en) Novel compounds
GB0308187D0 (en) Novel compounds
GB0301592D0 (en) Novel compounds
GB0301591D0 (en) Novel compounds
GB0304811D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)